Literature DB >> 8547978

[Anticardiolipin antibodies, cerebral ischemia and adrenal hemorrhage in a newborn infant].

G Teyssier1, V Gautheron, L Absi, C Galambrun, C Ravni, J C Lepetit.   

Abstract

BACKGROUND: Anticardiolipin antibodies, usually associated with vascular thrombosis in systemic lupus erythematosus, have been recently found associated with strokes in childhood, and acute adrenal hemorrhage in the adult. CASE REPORT: A 3 day-old fullterm newborn suffering from cerebrovascular ischemia and bilateral massive hemorrhage was found to have anticardiolipin antibodies detected during the neonatal period and 7 months later. There was no evidence of pathology in the mother or perinatal asphyxia. However, anticardiolipin antibodies were present in the mother 5 and 15 weeks after delivery.
CONCLUSION: Association of anticardiolipin antibodies and vascular thrombosis has never been reported in the neonate. Persistence of such antibodies favor the hypothesis that they are not transmitted by the mother; they could represent an early manifestation of primary antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547978     DOI: 10.1016/0929-693x(96)81285-1

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Neonatal cerebral venous thrombosis coexisting with bilateral adrenal hemorrhage.

Authors:  E Ergenekon; K Gücüyener; Y Atalay; A Serdaroğlu; T Tali; E Koç; C Türkyilmaz
Journal:  Indian J Pediatr       Date:  2000-08       Impact factor: 1.967

2.  Adrenal failure followed by status epilepticus and hemolytic anemia in primary antiphospholipid syndrome.

Authors:  Patrick Gerner; Michael Heldmann; Peter Borusiak; Vladimir Bures; Stefan Wirth
Journal:  Thromb J       Date:  2005-04-18

Review 3.  Clinical, laboratory, and therapeutic analyses of 21 patients with neonatal thrombosis and antiphospholipid antibodies: a literature review.

Authors:  Marcus Vinicius da Costa Peixoto; Jozélio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  J Immunol Res       Date:  2014-07-17       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.